49-year leukemia survivor: Why I support immunotherapy research at UT MD Anderson
I didn’t learn that Crystal Cruises was supporting UT MD Anderson’s immunotherapy research until I became a guest speaker for the cruise line in February 2026. But finding out that the company was donating a portion of its passengers’ booking fees to UT MD Anderson’s James P. Allison Institute™ through the end of 2026 was thrilling.
Why?
Because Dr. Allison won...
Understanding the gut-brain axis: 7 things to know
Have you ever found yourself thinking, “I don’t feel sick, exactly. I just don’t feel … right?”
If so, odds are that you’re correct...
Liver cancer survivor thankful for immunotherapy clinical trial
When Gordon Drygalski was diagnosed with early-stage liver cancer in December 2023, several friends told him to go to UT MD Anderson for treatment...
T cell prolymphocytic leukemia (TPLL): Symptoms, diagnosis and treatment
T cell prolymphocytic leukemia (TPLL) is an extremely rare form of leukemia that affects mainly older individuals. Only about 600 people will be diagnosed with it in the U.S. in any given year. So, most physicians have never seen it.
But how does TPLL differ from other types of leukemia? Does it have any distinguishing features? What are its symptoms, and how is it treated? Are there any clinical trials available...
Why getting an accurate lymphoma diagnosis matters
If you or a loved one has been diagnosed with lymphoma, you might think all you need to know is whether it’s Hodgkin or non-Hodgkin. But is...
Two-time tongue cancer survivor: Why I support research at UT MD Anderson
Sometimes, the most meaningful breakthroughs in medicine aren’t about saving your life — they’re about saving your quality of life. That was...
Stage 4 cervical cancer survivor thankful for immunotherapy clinical trial
Looking back, Paulette Burkhart believes the fatigue she began experiencing in 2023 was not because she needed to take vitamins or get more...
Understanding adenoid cystic carcinoma: Symptoms, treatment and outlook
Adenoid cystic carcinoma is a rare cancer of the secretory glands, which are glandular tissues that make and release substances such as saliva...
Astrocytoma survivor: Why I joined a targeted therapy clinical trial at UT MD Anderson
Until Groundhog Day 2018, I’d been living a healthy and normal life in Austin with my wife, Amy, and our two young children. Then one day,...
Total neoadjuvant therapy: A new era for patients with locally advanced rectal cancer
When rectal cancer advances to involve nearby lymph nodes but hasn’t spread to other areas of the body, it’s considered to be locally advanced...